Health

Tags:

In Infants with Egg or Milk Allergy, Can Future Peanut Allergy Be Predicted?

Early results from a study of more than 500 infants with egg or milk allergy indicate that they are highly likely to test positive for allergic antibodies that are specific to peanuts. This unexpected finding suggests that these infants are at risk for developing peanut allergy later in life and should be evaluated by a health care professional before introducing peanuts into their diet.

Tags:

More Americans Got Seasonal Flu Vaccination in 2009-10 than in Previous Years

CDC Report Shows Increase in Seasonal Flu Vaccinations, Greatest Increase among Children

More Americans Got Seasonal Flu Vaccination in 2009-10 than in Previous Years CDC Report Shows Increase in Seasonal Flu Vaccinations, Greatest Increase among Children

Tags:

Clean hands can prevent the spread of disease

WHO Invites healthcare workers, hospitals and organizations to promote improved hand hygiene to reduce infections.

7 May 2010 -- The WHO "Save lives: clean your hands" campaign invites healthcare workers, hospitals and organizations around the world to actively promote improved hand hygiene to reduce infections.

Tags:

NIH to evaluate effectiveness of male contraceptive skin gel

Researchers plan to enroll approximately 420 couples in clinical trial.

A clinical trial funded by the National Institutes of Health will evaluate a male contraceptive gel for its ability to prevent pregnancy. The gel formulation was developed by the Population Council and NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The Population Council will collaborate with NIH to conduct the study in NICHD’s Contraceptive Clinical Trials Network.

Tags:

Democratic Republic of the Congo begins first-ever multi-drug Ebola trial

The Ministry of Health of the Democratic Republic of the Congo (DRC) on November 26, announced that a randomized control trial has begun to evaluate the effectiveness and safety of drugs used in the treatment of Ebola patients. The trial is the first-ever multi drug trial for an Ebola treatment. It will form part of a multi-outbreak, multi-country study that was agreed to by partners under a World Health Organization (WHO) initiative.

Tags:

Clinical trial of investigational Ebola treatments begins in the Democratic Republic of the Congo

An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The randomized, controlled trial is enrolling patients of any age with confirmed Ebola virus disease (EVD) at a treatment unit in the city of Beni operated by ALIMA (The Alliance for International Medical Action), a medical humanitarian organization.

Tags:

WHO and partners launch new country-led response to put stalled malaria control efforts back on track

Reductions in malaria cases have stalled after several years of decline globally, according to the new World malaria report 2018. To get the reduction in malaria deaths and disease back on track, WHO and partners are joining a new country-led response, on November 19, launched, to scale up prevention and treatment, and increased investment, to protect vulnerable people from the deadly disease.

Tags:

NIH researchers discover neural code that predicts behavior

Neurons in an ancient part of the brain encode decisions based on visual information.

Scientists at the National Eye Institute (NEI) have found that neurons in the superior colliculus, an ancient midbrain structure found in all vertebrates, are key players in allowing us to detect visual objects and events.

Tags:

Eyes of CJD patients show evidence of prions

Finding could help early diagnosis, raise concern for eye exams and transplants.

National Institutes of Health scientists and their colleagues have found evidence of the infectious agent of sporadic Creutzfeldt-Jakob disease (CJD) in the eyes of deceased CJD patients. The finding suggests that the eye may be a source for early CJD diagnosis and raises questions about the safety of routine eye exams and corneal transplants. Sporadic CJD, a fatal neurodegenerative prion disease of humans, is untreatable and difficult to diagnose.

Tags:

Study explains behavioral reaction to painful experiences

Exposure to uncomfortable sensations elicits a wide range of appropriate and quick reactions, from reflexive withdrawal to more complex feelings and behaviors. To better understand the body’s innate response to harmful activity, researchers at the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health, have identified activity in the brain that governs these reactions.